Our transactions
Our Track Record
Over the last couple of years, Agile has successfully advised on over €1.1 billion worth of transactions and has closed 18 transactions in the last 18–24 months with global investors or strategic players across Europe, North America, Asia, and beyond.
Clinomic
ICU Leader Clinomic Secures €23M Series B Investment to Drive AI & Data Innovation in Critical Care.
Cilcare
Cilcare completes a €40 million Series A to accelerate the development of innovative treatments for early hearing loss.
RIBOPRO
RIBOPRO Secures Series A funding to accelerate mRNA-Based technologies.
Discure Technologies
Discure Technologies developer of the Discure System, a bioelectronic implantable device for the treatment of degenerative disc disease (DDD), announces a $16 million series A.
Cilcare
Cilcare, a leading biotech company specializing in auditory sciences, announces a €400 million agreement with Shionogi.
BIOPHTA
BIOPHTA raises €6.5 million seed funding to transition its new standard of care for eye diseases to the clinical stage.
Acticor Biotech
Acticor Biotech completes a capital increase for a total gross amount of €8 million.
Undisclosed
New York based biotech company raises $110M series C to develop innovative treatments for schizophrenia.
Acticor Biotech
Acticor Biotech completes a capital increase for a total gross amount of approximately €2.6 million.
APICES
Spanish CRO APICES boosts its expansion and growth plans with the integration of the French CRO Kappa Santé.
Pherecydes
Merger of Erytech and Pherecydes and renamed Phaxiam Therapeutics.
Undisclosed
A company developing a microfluidic Cell and Gene Therapy manufacturing platform raises €16.5 million in seed funding.
Acticor Biotech
Acticor Biotech successfully completes a capital increase for a total gross amount of €12.2 million.
Backbone
Companion Spine acquires Backbone SAS, expanding its portfolio of medical implants dedicated to treating spine and back pain.
Lattice Medical
LATTICE MEDICAL, a French Medtech company providing patients and healthcare professionals with personalized tissue reconstruction solutions, closed a second round of financing of €8 million.
Incepto
Incepto, the AI platform for medical imaging, raised €27 million to support its European development.
Neurofenix
Neurofenix closes a $7 million Series A financing round led with AlbionVC as lead investor, with the participation of HTH, InHealth Ventures, and of existing investors.
Ludocare
Ludocare, specialist in digital therapies dedicated to pediatrics, announces a €4.2 million fund-raising round.
Spine Innovations
Spineway, a specialist in innovative implants for severe spinal pathologies, acquires 100% of the capital of Spine Innovations, a French company specializing in cervical and lumbar disc prostheses.
Domain Therapeutics
Domain Therapeutics raises $42 million Series A financing to accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs.
FineHeart
FineHeart S.A, a preclinical medical device designed to address the unmet need of patients suffering from severe heart failure, raised a €15 million series B funding round.
Acticor Biotech
Success of Acticor Biotech’s Initial Public Offering on the Euronext Growth® market, with €15.5 million raised.
PKvitality
PKvitality, a French company specialized in bio wearables, has signed an agreement with Beurer GmBH, providing PKvitality with €2.25 million funding to further develop the K’Watch and reach FIH.
Acticor Biotech
Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, has raised €7 million in addition to its Series B, now completed at €22.3 million.
TransCure bioServices
TransCure bioServices, a French one-stop-shop preclinical services company dedicated to in-vivo full human immune system mouse models, completed a €2.5 million funding with Financière Arbevel.
Valcare Medical
Valcare Medical, a medtech company developing innovative minimally-invasive technologies for the treatment of mitral regurgitation, raises $26 millions series B led by a Chinese Medical Device company.
Acticor Biotech
Acticor biotech signed a €60 million regional development and commercialization agreement with China Medical System Holding Limited®.
EOS Imaging
EOS imaging has entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., for c. €15.1 million.
EOS Imaging
EOS IMAGING, the pioneer of 2D/3D imaging and data solutions for orthopedics, completed an offering of bonds convertible for a nominal amount of c. €29.5 million.
STENTYS
STENTYS, a medtech company commercializing the Xposition S self-apposing coronary stent, acquired MINVASYS, independent specialist in innovative coronary devices marketed worldwide, for €11.8 million.
Cellnovo
Cellnovo concludes a loan agreement for up to €20 million from the European Investment Bank.
Cellnovo
Cellnovo Group, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, announced a capital raise of €17.5 million.
Cellnovo
Cellnovo raises circa €5.4 million in capital increase without preferential subscription rights.